Reaction
Skin Texture Abnormal reporting signals
As of the last recalculation, Skin Texture Abnormal appears in 927 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is NEMOLIZUMAB-ILTO (PRR 23.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nemolizumab-Ilto | 13 | 23.3 | 23.3 |
| Tretinoin | 8 | 22.3 | 22.3 |
| Asfotase Alfa | 8 | 18.1 | 18.1 |
| Avapritinib | 7 | 13.1 | 13.1 |
| Encorafenib | 4 | 9.1 | 9.1 |
| Dupilumab | 152 | 8.3 | 8.3 |
| Adapalene | 62 | 8.1 | 8.1 |
| Sulfur | 3 | 8.0 | 8.0 |
| Crisaborole | 3 | 7.0 | 7.0 |
| Minoxidil Foam 5% (Womens) | 10 | 6.9 | 6.9 |
| Salicylic Acid | 12 | 5.1 | 5.1 |
| Minoxidil | 10 | 5.0 | 5.0 |
| Abaloparatide | 5 | 3.8 | 3.8 |
| Copper | 5 | 2.6 | 2.6 |